This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sirtris Pharmaceuticals, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Karl D Normington
Introduction
Karl D Normington is an accomplished inventor based in Acton, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate sirtuins, which are proteins involved in cellular regulation and longevity.
Latest Patents
Normington holds a patent for "Fused heterocyclic compounds and their use as sirtuin modulators." This patent describes novel sirtuin-modulating compounds and methods for their use. These compounds have the potential to increase the lifespan of cells and treat or prevent a variety of diseases and disorders. These include conditions related to aging, stress, diabetes, obesity, neurodegenerative diseases, and cancer, among others. The patent also covers compositions that combine sirtuin-modulating compounds with other therapeutic agents.
Career Highlights
Karl D Normington is associated with Sirtris Pharmaceuticals, Inc., a company known for its focus on developing therapies that target sirtuins. His work has contributed to advancing the understanding of how these compounds can be utilized in medical treatments.
Collaborations
Normington has collaborated with notable colleagues, including Michael V Milburn and Jill C Milne, who have also contributed to the research and development of sirtuin-modulating compounds.
Conclusion
Karl D Normington's innovative work in the field of sirtuin modulation showcases the potential for new therapeutic approaches to treat a range of diseases. His contributions continue to influence the landscape of medicinal chemistry and offer hope for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile